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Figure 1: Genome-wide Linkage analysis result of the BFIS family.  
(A) Whole genome linkage results obtained from Allegro module with AD inheritance and 70% penetrance model. (B) Linkage analysis result 
of SimWalk module with AD inheritance and 70% inheritance model focusing on chromosome 19 linkage region.  
 
 
 Figure 2: Haplotypes at the linkage region. Co-segregating risk haplotype is shown as 
black bar. Individuals with a sample ID are actually genotyped.  
 
 
 
 
 
  
Figure 3: The synonymous variant in the SCN1B gene. 
(A) NM_001037.3, c492T>C transition in the index patient (4BF14). Arrow indicates the   
presence of the variant in heterozygous state (T/C). (B) PESX analysis. Red sequences show 
splicing silencers and green sequences show splicing enhancers. Upper panel shows the wild 
type sequence, lower panel shows the sequence with altered nucleotide which is underlined with 
yellow line. 
  
 
Figure 4: The family pedigree. 
The family pedigree shows the segregation of SCN1B c.492T>C/p.Tyr164Tyr and PRRT2 c.649dupC/p.Arg217Profs*8 variations. The 
two individuals analyzed by WES are shown by an arrow. 4BF14 was the index patient. Phenotype information was not available for 
individuals marked in gray.
  
Figure 5: The minigene assay for the SCN1B c.492T>C/p.Tyr164Tyr variation. 
Left panel shows the agarose gel picture. cDNA amplification of mRNA isolated from Shsy-5y cells transfected by pSpliceExpress plasmid 
with SCN1B exon 4 with c.492T>C/p.Tyr164Tyr mutation (lane 2), wild type SCN1B exon 4 (lane 3) and 300 bp empty vector with the two rat 
exons (lane 4). Lane 1 shows 100 bp ladder (Fermentas) and lane 5 shows no plasmid control. Right panel shows the schematic representation of 
the plasmid with the insert and the empty vector alone. Yellow and green arrows represent Rat Insulin 2 gene exon 3 and exon 2, respectively. Blue 
arrow represents human SCN1B gene exon 4. Pink and light blue arrows represent primer locations for PCR amplification. 
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Supplementary Figure 1:(A) Expected fragments: top sequence rat insulin exons with 
GABRG2 exon 6 and intron retention, middle sequence rat insulin exons with GABRG2 exon 6, 
and bottom sequence rat insulin exons only. Orange and blue arrows represent RT-PCR primer 
binding sites. (B) RT-PCR products on 2 per cent agarose gel: M: 100 bp DNA length marker, 
S2: variant created by site directed mutagenesis, WT2: wild type 2. (C) Sanger sequencing 
results for mutant (upper panel) and wild type (bottom panel) of GABRG2 exon6. 
 Supplementary Table 1: Variants validated by Sanger sequencing and included in segregation analysis. 
 
 
 
dbSNP ID MAF Locus 
(GRCh37) 
Gene ID Gene Amino acid Change Change Biotype LOD Score 
rs60235724 0.3770/1888 19:34304262 79047 KCTD15 XP_011525598.1:p.Tyr297Leufs Frameshift 2,02 
rs200278064 T=0.0198/99 19:35448919 126375 ZNF792 NP_787068.3:p.Ala614Thr Non-synonymous 3,01 
rs201800628 G=0.0198/99 19:35448945 126375 ZNF792 NP_787068.3:p.Ser605Thr Non-synonymous 3,01 
rs558298045 T=0.0018/9 19:35500319 57655 GRAMD1A NM_020895.3:c.220-8C>T -8 nucleotide 
from splice site 
3,01 
rs535042320 C=0.0014/7 19:35530064 6324 SCN1B NP_001028.1:p.Tyr164Tyr Synonymous 3,01 
rs730882071 NA 16:29813703 112476 PRRT2 NP_001243371.1:p.Arg217Glufs Frameshift 1,08 
rs137852776 C=0.0018/9 6:52317597 114327 EFHC1 NP_060570.2:p.Phe229Leu Non-synonymous 0 
rs115466046 T=0.0044/22 1: 160012270 3766 KCNJ10 NP_002232.2:p.Arg18Gln Non-synonymous 0 
 
